Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.67T | 1.64T | 1.40T | 1.03T | 898.17B | 1.51T |
Gross Profit | 408.94B | 395.45B | 268.70B | 43.25B | -77.42B | 378.06B |
EBITDA | 310.54B | 328.61B | 245.33B | 61.27B | -72.08B | 331.08B |
Net Income | 103.72B | 98.76B | 88.53B | -113.20B | -233.21B | 89.38B |
Balance Sheet | ||||||
Total Assets | 3.61T | 3.78T | 3.74T | 3.70T | 3.48T | 3.28T |
Cash, Cash Equivalents and Short-Term Investments | 134.72B | 233.47B | 290.17B | 319.92B | 210.31B | 78.66B |
Total Debt | 1.40T | 1.48T | 1.57T | 1.64T | 1.48T | 1.00T |
Total Liabilities | 2.40T | 2.55T | 2.59T | 2.63T | 2.52T | 2.05T |
Stockholders Equity | 1.10T | 1.11T | 1.03T | 968.94B | 852.91B | 1.12T |
Cash Flow | ||||||
Free Cash Flow | 162.62B | 68.96B | 27.95B | -326.95B | -345.34B | -25.00B |
Operating Cash Flow | 162.62B | 318.31B | 273.96B | -86.47B | -103.30B | 240.15B |
Investing Cash Flow | 0.00 | -243.65B | -214.90B | -188.71B | -211.69B | -268.66B |
Financing Cash Flow | 0.00 | -131.62B | -88.77B | 384.69B | 446.75B | -29.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $35.54B | 32.55 | 10.62% | 0.48% | 5.21% | 24.15% | |
78 Outperform | $57.67B | 17.47 | 24.52% | 2.11% | 0.70% | 135.08% | |
76 Outperform | $10.59B | 14.26 | 9.93% | 1.48% | -3.15% | 79.62% | |
73 Outperform | $61.82B | 19.61 | 26.13% | 1.58% | -2.39% | -7.80% | |
73 Outperform | $5.53B | 19.63 | 11.64% | 1.57% | 12.07% | 11.93% | |
71 Outperform | $138.26B | 20.85 | 42.47% | 2.34% | 0.63% | 5.93% | |
58 Neutral | $1.33B | 4.26 | -2.93% | 8.38% | 3.41% | -51.76% |